Christopher Mallow

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.419Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf185

Top 44%

0.419DataRank

Top 44%7 citations

Elizabeth Harker, Seana Cleary, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell +42 more

Papers

Driven by 26 papers — median percentile 56. Top paper: “Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024”.

Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf185

Top 44%

0.419DataRank

Top 44%7 citations

Elizabeth Harker, Seana Cleary, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell +42 more

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7034e2

N/A

0DataRank · unranked

246 citations

Wesley H. Self, Eric A. Naioti, Adit A. Ginde, David J. Douin, Samantha M. Olson +95 more

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab619

N/A

0DataRank · unranked

23 citations

Eric A. Naioti, Wesley H. Self, Adit A. Ginde, David J. Douin, H. Keipp Talbot +94 more

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

BMJ(2022)10.1136/bmj-2021-069761

N/A

0DataRank · unranked

684 citations

Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +54 more

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7112e1

N/A

0DataRank · unranked

184 citations

Wesley H. Self, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot +53 more

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

BMJ(2022)10.1136/bmj-2022-072065

N/A

0DataRank · unranked

115 citations

Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +35 more

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7104a2

N/A

0DataRank · unranked

100 citations

Manish M. Patel, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot +94 more

Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7142a3

N/A

0DataRank · unranked

60 citations

Levi N. Bonnell, Katherine Adams, Manjusha Gaglani, Adit A. Ginde, David J. Douin +94 more

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac118

N/A

0DataRank · unranked

39 citations

Mark W. Tenforde, Manjusha Gaglani, H. Keipp Talbot, Adit A. Ginde, Tresa McNeal +50 more

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness

Influenza and Other Respiratory Viruses(2022)10.1111/irv.13023

N/A

0DataRank · unranked

40 citations

Samantha M. Olson, Wesley H. Self, Adit A. Ginde, Nicholas M. Mohr, Manjusha Gaglani +26 more

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022

Clinical Infectious Diseases(2022)10.1093/cid/ciac869

N/A

0DataRank · unranked

23 citations

Manish M. Patel, Nathaniel M. Lewis, Katherine Adams, Manjusha Gaglani, Jay S. Steingrub +26 more

Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

Clinical Infectious Diseases(2022)10.1093/cid/ciac381

N/A

0DataRank · unranked

19 citations

Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde +56 more

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac698

N/A

0DataRank · unranked

13 citations

Nancy L. Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A. Ginde +83 more

Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study

medRxiv(2022)10.1101/2022.02.06.22270558

N/A

0DataRank · unranked

32 citations

Mark W. Tenforde, James D. Chappell, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +55 more

Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States

medRxiv(2022)10.1101/2022.06.09.22276228

N/A

0DataRank · unranked

16 citations

Jillian P. Rhoads, Diya Surie, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal +54 more

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7240a2

N/A

0DataRank · unranked

102 citations

Katharine A. Yuengling, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A. Ginde +48 more

Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023

Clinical Infectious Diseases(2023)10.1093/cid/ciad677

N/A

0DataRank · unranked

35 citations

Yuwei Zhu, Ithan D. Peltan, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande +85 more

Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022

Clinical Infectious Diseases(2023)10.1093/cid/ciad276

N/A

0DataRank · unranked

33 citations

Katherine Adams, Wesley H. Self, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande +82 more

Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad061

N/A

0DataRank · unranked

8 citations

Christopher Blair, Yuwei Zhu, James D. Chappell, Manjusha Gaglani, Tresa McNeal +37 more

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7308a5

N/A

0DataRank · unranked

77 citations

Amanda B. Payne, Wesley H. Self, Elizabeth Rowley, Kristin Dascomb, Malini B. DeSilva +94 more

Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae584

N/A

0DataRank · unranked

11 citations

Elizabeth Harker, Lauren Grant, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell +88 more

Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023

Influenza and Other Respiratory Viruses(2024)10.1111/irv.70027

N/A

0DataRank · unranked

10 citations

Diya Surie, Yuwei Zhu, Adam S. Lauring, Manjusha Gaglani, Tresa McNeal +48 more

Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023

Vaccine(2024)10.1016/j.vaccine.2024.126492

N/A

0DataRank · unranked

8 citations

Elizabeth Harker, Aleda M. Leis, Yuwei Zhu, H. Keipp Talbot, Carlos G. Grijalva +43 more

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae502

N/A

0DataRank · unranked

0 citations

Yuwei Zhu, Ine Sohn, William B. Stubblefield, Michael B. Streiff, Manjusha Gaglani +89 more

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7038e1

N/A

0DataRank · unranked

455 citations

Mark W. Tenforde, Jillian P. Rhoads, Manjusha Gaglani, Adit A. Ginde, David J. Douin +94 more

Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025

MMWR Morbidity and Mortality Weekly Report(2025)10.15585/mmwr.mm7406a1

N/A

0DataRank · unranked

80 citations

Sean Chickery, A Webber, Toan C. Ong, Elizabeth Rowley, Malini B. DeSilva +94 more

Christopher Mallow

Indexed papers

Top data-sharing exemplar

Papers